City Therapeutics, Inc. raised $135M in a Series A financing led by ARCH Venture Partners to advance RNA interference-based medicines.
Amount Raised
$135 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
City Therapeutics, Inc. announced its launch today with a vision to lead the future of RNA interference (RNAi)-based medicine. The $135 million Series A financing will help the company build a robust product engine to expand the therapeutic reach of RNAi-based medicines.
Quick answer
City Therapeutics raised $135 Million in a Series A round, dated October 8, 2024. Investors: AN Ventures, Fidelity Management & Research Company, Invus, Slate Path Capital, Rock Springs Capital, Regeneron Ventures and ARCH Venture Partners. City Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did City Therapeutics raise?
- City Therapeutics raised $135 Million in a Series A round on October 8, 2024.
- Who invested in City Therapeutics?
- AN Ventures, Fidelity Management & Research Company, Invus, Slate Path Capital, Rock Springs Capital, Regeneron Ventures and ARCH Venture Partners are named as investors in this round.
- What does City Therapeutics do?
- City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines.
- Where is City Therapeutics based and how big is it?
- City Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 75 employees.
- Who are the decision-makers at City Therapeutics?
- Fundz holds 1 contact at City Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as City Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Intensity Therapeutics raised $3.6M (Seed) on November 21, 2024.
- Biofrontera raised $4.2M (Seed) on November 21, 2024.
- Debiopharm raised $5.8M (Funding Round) on November 21, 2024.
- HCW Biologics raised $6.9M on November 20, 2024.
- Adipo Therapeutics raised $4.7M (Seed) on November 19, 2024.
- Qualigen Therapeutics raised $5.1M on November 18, 2024.
Who to call at City Therapeutics, and when
A new round usually means City Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day City Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at City Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at City Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment City Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCity Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.